News | April 17, 2007

Masimo Files for IPO of Up to $150M

April 18, 2007 - Masimo Corp. filed with the Securities and Exchange Commission for an initial public offering of up to $150 million in common stock. The Irvine, CA-based medical technology company makes noninvasive patient monitoring products.

The company didn't disclose how many shares will be offered, nor did it provide an estimated price range for the offering.

The company said it expects to use about $15 million to $20 million of the net proceeds from this offering in capital expenditures and deferred cost of sales, primarily representing the placement of equipment under long-term sensor purchase contracts, and about $7.5 million in miscellaneous capital purchases.

The company said it intends to use the remainder net proceeds for ongoing research and development, sales and marketing activities and increased costs associated with becoming a public company.

Piper Jaffray, Deutsche Bank Securities, Cowen and Co. and Thomas Weisel Partners LLC are listed as underwriters for the offering.

The company said it plans to list its stock on the Nasdaq Global Market, under the symbol of MASI.

For the year 2006, the company's net income increased to $181.6 million from 2005's $33.4 million. Its 2006 revenue more than doubled to $224 million from $108 million in 2005, according to the company's prospectus.

Related Content

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures

Philips launches Azurion with FlexArm to set new standard for the future of image-guided procedures.

News | Radiology Imaging | December 12, 2019
December 12, 2019 — Philips and the Regional Medical Center
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
ASTRO 2019 to Feature Clinical Experience and Patient Outcomes With Viewray MRIdian
News | Image Guided Radiation Therapy (IGRT) | September 11, 2019
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation...
Beamscan MR 3D water phantom – the first 3-D water phantom for magnetic resonance (MR)-guided radiotherapy
News | Radiation Therapy | August 27, 2019
Radiation dosimetry company announced plans to exhibit its full range of radiation therapy dosimetry solutions for...
First Cancer Patient Treated With Accuray Radixact System With Synchrony Motion Tracking
News | Image Guided Radiation Therapy (IGRT) | August 21, 2019
Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have...
MD Anderson to Expand Proton Therapy Center

The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec.

News | Proton Therapy | August 08, 2019
The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a...